Independent validation

Backtesting Robustness Validation

Independent robustness review for teams that need to know how much of a backtest still stands up once scenario pressure and execution friction are taken seriously.

Lucien Allen provides technical architecture, engineering, governance, and operational advisory. The work does not constitute investment advice.

Price band
$1K-$5K
Timeline
1 to 2 weeks
Offer class
Diagnostic

Problem

Where this becomes useful.

A strategy can look compelling in a backtest and still be too brittle for confident deployment because scenario coverage, sensitivity framing, or execution assumptions were never challenged hard enough.

Who it is for

  • Funds validating a strategy before production use or allocation increases
  • Fintech builders packaging a trading product for launch
  • Technical operators who need a second set of eyes on assumptions and sensitivity

Likely outcomes

  • Sharper confidence bounds around what the backtest does and does not support
  • Clearer view of regime sensitivity, data dependence, and execution fragility
  • Stronger internal evidence before a strategy is promoted or presented

Deliverables

What the team walks away with.

Review of backtest methodology, assumptions, and validation artifacts

Robustness matrix covering scenario stress, sensitivity, and production relevance

Findings memo highlighting where confidence is earned versus where it is still overstated

Proof

Sanitized evidence from adjacent mandates.

backtest diagnostic

Related case

Robustness and Sensitivity Pack

Sanitized validation evidence illustrating how strategy assumptions were pressure-tested across scenario, sensitivity, and production-relevance checks.

Artifact
Robustness and sensitivity review pack
Why it matters
The artifact shows scenario coverage, sensitivity framing, and the specific confidence gaps that remained after validation artifacts were compared.

FAQ

Common questions before an engagement.

  • Is this meant to replace an internal research review?

    No. It supplements internal work by applying a tighter external standard to robustness, production relevance, and evidence quality.

  • Do you provide an investment opinion?

    No. The work is technical validation and methodology review, not investment advice.

Diagnostic

When the first step is well-defined, the rest of the scope usually becomes clearer.